Development of aberrant crypt foci involves a fission mechanism as revealed by isolation of aberrant crypts

Japanese Journal of Cancer Research

Volumn 87, Issue 12, 1996, Pages 1199-1203

  Fujimitsu, Yasunobu ^a,b   Nakanishi, Hayao ^a   Inada, Ken Ichi ^a   Yamachika, Takasuke ^a   Ichinose, Masutaro ^a   Fukami, Hiroko ^a   Tatematsu, Masae ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Aberrant crypt foci; Crypt isolation technique; Fission mechanism

Indexed keywords

1,2 DIMETHYLHYDRAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIVISION; CELL ISOLATION; CELL STRUCTURE; COLON; CRYPT CELL; MALE; NONHUMAN; PRECANCER; PRIORITY JOURNAL; RAT;

EID: 0030455701     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1996.tb03133.x     Document Type: Article

References (22)

1. Bird, R. P. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett., 37, 147-151 (1987).
2. McLellan, E. A. and Bird, R. P. Aberrant crypts: potential preneoplastic lesions in the murine colon. Cancer Res., 48, 6187-6192 (1988).
3. McLellan, E. A., Medline, A. and Bird, R. P. Dose response and proliferative characteristics of aberrant crypt foci: putative preneoplastic lesions in rat colon. Carcinogenesis, 12, 2093-2098 (1991).
4. Pretlow, T. P., Barrow, B. J., Ashton, W. S., O'Riordan, M. A., Pretlow, T. G., Jurcisek, J. A. and Stellato, T. A. Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res., 51, 1564-1567 (1991).
5. Roncucci, L., Stamp, D., Medline, A., Cullen, J. B. and Bruce, W. R. Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum. Pathol., 22, 287-294 (1991).
6. Pretlow, T. P., O'Riordan, M. A., Pretlow, T. G. and Stellato, T. A. Aberrant crypts in human colonic mucosa: putative preneoplastic lesions. J. Cell. Biochem., 16 (Suppl. G), 55-62 (1992).
7. Pretlow, T. P., O'Riordan, M. A., Kolman, M. F. and Jurcisek, J. A. Colonic aberrant crypts in azoxymethane-treated F344 rats have decreased hexosaminidase activity. Am. J. Pathol., 136, 13-16 (1990).
8. Stopera, S. A. and Bird, R. P. Expression of ras oncogene mRNA and protein in aberrant crypt foci. Carcinogenesis, 13, 1863-1868 (1992).
9. Stopera, S. A., Murphy, L. C. and Bird, R. P. Evidence for a ras gene mutation in azoxymethane-induced colonic aberrant crypts in Sprague-Dawley rats: earliest recognizable precursor lesions of experimental colon cancer. Carcinogenesis, 13, 2081-2085 (1992).
10. Vivona, A. A., Shpitz, B., Medline, A., Bruce, W. R., Hay, K., Ward, M. A., Stern, H. S. and Gallinger, S. K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis. Carcinogenesis, 14, 1777-1781 (1993).
11. McLellan, E. A., Medline, A. and Bird, R. P. Sequential analyses of the growth and morphological characteristics of aberrant crypt foci: putative preneoplastic lesions. Cancer Res., 51, 5270-5274 (1991).
12. Maskens, A. P. Histogenesis of colon glands during post-natal growth. Acta Anat., 100, 17-26 (1978).
13. Maskens, A. P. and Dujardin, L. R. Kinetics of tissue proliferation in colorectal mucosa during post-natal growth. Cell Tissue Kinet., 14, 467-477 (1981).
14. Bjerknes, M. and Cheng, H. Methods for the isolation of intact epithelium from the mouse intestine. Anat. Rec., 199, 565-574 (1981).
15. Yamashita, N., Minamoto, T., Onda, M., Esumi, H. Increased cell proliferation of azoxymethane-induced aberrant crypt foci of rat colon. Jpn. J. Cancer Res., 85, 692-698 (1994).
16. Griffiths, D. F., Davies, S. J., Williams, D., Williams, G. T. and Williams, E. D. Demonstration of somatic mutation and colonic crypt clonality by X-linked enzyme histochemistry. Nature, 333, 461-463 (1988).
17. Tatematsu, M., Masui, T., Fukami, H., Yamamoto, M., Nakanishi, H., Inada, K., Kusakabe, M. and Sakakura, T. Primary monoclonal and secondary polyclonal growth of colon neoplastic lesions in C3H/HeN↔BALB/c chimeric mice treated with 1,2-dimethylhydrazine: immunohistochemical detection of C3H strain-specific antigen and simple sequence length polymorphism analysis of DNA. Int. J. Cancer, 66, 234-238 (1996).
18. Tudek, B., Bird, R. P. and Bruce, W. R. Foci of aberrant crypts in the colons of mice and rats exposed to carcinogens associated with foods. Cancer Res., 49, 1236-1240 (1989).
19. Hardman, W. E., Cameron, I. L., Heitman, D. W. and Contreras, E. Demonstration of the need for end point validation of putative biomarkers: failure of aberrant crypt foci to predict colon cancer incidence. Cancer Res., 51, 6388-6392 (1991).
20. Thorup, I., Meyer, O. and Kristiansen, E. Influence of a dietary fiber on development of dimethylhydrazine-induced aberrant crypt foci and colon tumor incidence in Wistar rats. Nutr. Cancer, 21, 177-182 (1994).
21. Tatematsu, M., Nagamine, Y. and Farber, E. Redifferentiation as a basis for remodeling of carcinogen-induced hepatocyte nodules to normal appearing liver. Cancer Res., 43, 5049-5058 (1983).
22. Chang, W. W. and Leblond, C. P. Renewal of the epithelium in the descending colon of the mouse. I. Presence of three cell populations: vacuolated-columnar, mucous and argentaffin. Am. J. Anat., 131, 73-99 (1971).